Delivery Order SPE2DB20D9127-SPE2DB25FPRK6
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $110,928.72 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The delivery order, which is set to be completed by July 22, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg capsules (84-count units). This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of September 9, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency on August 13, 2025, for the supply of Trikafta 100-50-75 mg/150 mg medications. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a direct pharmaceutical supply to support Department of Defense healthcare operations. The contract was awarded without...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on August 5, 2025. The delivery order, which expires August 6, 2025, is for Trikafta 100-50-75 mg/150 mg pharmaceutical products. This award was issued without a set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $112,587.38 by the Defense Logistics Agency on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract covers the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14, a prescription medication used in the treatment of cystic fibrosis. This delivery order was issued without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,754.56 by the Defense Logistics Agency on September 11, 2025, for the supply of Trikafta 100-50-75 mg/150 mg pharmaceutical product. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation. This award leverages DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $205,854.67 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 12, 2025. The delivery order covers Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units and is structured as a firm fixed-price contract with an ultimate completion date of September 15, 2025. This award does not utilize a set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $75,595.28 by the Defense Logistics Agency (DLA) on September 11, 2025, with a completion date of September 12, 2025. The delivery order covers Trikafta 100-50-75 mg/75 mg packets in quantities of 14, a prescription medication used in the treatment of cystic fibrosis. This award was made without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $77,266.28 by the Defense Logistics Agency on August 12, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14 units. The delivery order, which carries a firm fixed-price structure with no set-aside designation, is scheduled for completion by August 13, 2025, and will be fulfilled from the company's Park Ridge...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB25FPRK6Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $55,464.36 by the Defense Logistics Agency on September 10, 2025, with an ultimate completion date of September 11, 2025. The delivery order, identified as 4569433033, covers the supply of Trikafta 100-50-75 mg/150 mg in a package of 84 units. This award was issued without a set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace based on its established capabilities and pricing. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities worldwide. The company has demonstrated consistent success in securing federal pharmaceutical contracts across diverse product categories, leveraging its status as a woman-owned small business to support the Department of Defense's critical pharmaceutical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.5k | 9/10/25 |